Cellasene Sales Top $5 Mil. In First Two Months On Market
This article was originally published in The Tan Sheet
Executive Summary
Cellasene cellulite reducing dietary supplement is outselling other supplements, with $5.1 mil. in sales at food, drug and mass merchandise outlets, Rexall Sundown announced at a news conference in New York City May 25. The conference was held in response to emerging skepticism about the product's effectiveness and the science on which the product is based. The Federal Trade Commission reportedly is investigating Cellasene.
You may also be interested in...
Rexall Retail Sales Soar 43% To $135 Mil. In Second Quarter
Osteo Bi-Flex, Metab-O-Lite and the recently acquired Met-Rx business led Rexall Sundown to a 27% sales jump in the fiscal second quarter ended Feb. 29, the firm announced March 23.
Rexall Retail Sales Soar 43% To $135 Mil. In Second Quarter
Osteo Bi-Flex, Metab-O-Lite and the recently acquired Met-Rx business led Rexall Sundown to a 27% sales jump in the fiscal second quarter ended Feb. 29, the firm announced March 23.
Rexall Retail Sales Soar 43% To $135 Mil. In Second Quarter
Osteo Bi-Flex, Metab-O-Lite and the recently acquired Met-Rx business led Rexall Sundown to a 27% sales jump in the fiscal second quarter ended Feb. 29, the firm announced March 23.